Oragenics, Inc.
(NYSE Amex Equities : OGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.42%171.381.3%$493.17m
BIIBBiogen Inc.
-1.10%226.601.3%$458.96m
CELGCelgene Corporation
-0.21%95.431.3%$443.53m
GILDGilead Sciences, Inc.
-0.57%66.790.9%$425.86m
ILMNIllumina, Inc.
1.48%313.543.5%$309.69m
REGNRegeneron Pharmaceuticals, Inc.
-0.78%312.792.6%$291.27m
AAgilent Technologies, Inc.
1.83%68.941.6%$213.46m
VRTXVertex Pharmaceuticals Incorporated
-0.56%172.051.9%$178.88m
EXASExact Sciences Corporation
3.11%96.9225.3%$168.09m
ALXNAlexion Pharmaceuticals, Inc.
1.83%127.622.0%$150.33m
BMRNBioMarin Pharmaceutical Inc.
2.00%88.714.3%$118.39m
INCYIncyte Corporation
1.30%81.552.5%$108.36m
SRPTSarepta Therapeutics, Inc.
2.10%120.7414.7%$106.84m
ALNYAlnylam Pharmaceuticals, Inc
1.61%69.019.2%$97.02m
IONSIonis Pharmaceuticals, Inc.
-3.62%64.718.2%$93.65m

Company Profile

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.